← All indications
Jaundice
A clinical manifestation of HYPERBILIRUBINEMIA, characterized by the yellowish staining of the SKIN; MUCOUS MEMBRANE; and SCLERA. Clinical jaundice usually is a sign of LIVER dysfunction.
Subtype terms (1)
More specific conditions that are subtypes of Jaundice in the MeSH hierarchy.
- Jaundice, Obstructive
11 drugs (6 approved, 5 experimental)
Drugs by status
Approved for this indication (1)
Phase 3 trials (3)
Phase 2 trials (3)
Phase 1 trials (2)
Other trials (1)
Organizations
Organization Involved with Phase 3 Indications (10)
- Polysan, Ltd.
- Fudan University
- Petrov Research Institute of Oncology
- BioEq
- St. Petersburg Mechnikov State Medical Academy
- Irkutsk Regional Clinical Hospital
- Avicenna Medical Center
- Regional Clinical oncologic center, Omsk region
- State Budgetary Health Care Institution "City Hospital № 26"
- Leningrad Regional Clinical Hospital
Organization Involved with Phase 2 Indications (12)
- Cato Research
- InfaCare Pharmaceuticals Corporation
- National Institute of Neurological Disorders and Stroke (NINDS)
- University Clinical Centre of Kosova
- University of Florida
- University of Rochester
- Vinmec International Hospital
- University of Zagreb
- Columbia University
- All India Institute of Medical Sciences
- University of Kosovo
- People's Liberation Army of China
Organization Involved with Other Experimental Indications (2)